VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $11,763,000 | -7.7% | 506,140 | -36.7% | 0.24% | +15.6% |
Q1 2018 | $12,742,000 | -39.7% | 800,104 | -21.4% | 0.20% | -45.6% |
Q4 2017 | $21,136,000 | +2058.9% | 1,017,300 | +1385.1% | 0.38% | +2413.3% |
Q3 2017 | $979,000 | -59.5% | 68,500 | -51.0% | 0.02% | -58.3% |
Q2 2017 | $2,417,000 | +47.3% | 139,700 | -6.1% | 0.04% | +50.0% |
Q1 2017 | $1,641,000 | +197.3% | 148,755 | +290.6% | 0.02% | +140.0% |
Q4 2016 | $552,000 | -79.1% | 38,083 | -64.6% | 0.01% | -76.2% |
Q3 2016 | $2,642,000 | +294.9% | 107,700 | +323.5% | 0.04% | +281.8% |
Q1 2016 | $669,000 | +149.6% | 25,432 | +1595.5% | 0.01% | +175.0% |
Q3 2015 | $268,000 | -98.5% | 1,500 | -98.9% | 0.00% | -98.3% |
Q3 2014 | $18,232,000 | -52.7% | 138,963 | -54.6% | 0.24% | -48.7% |
Q2 2014 | $38,580,000 | – | 305,899 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |